Dynamic changes of serum hbv pgrna levels in patients with chronic hepatitis B treated with entecavir or peg-interferon

被引：1
|
作者：
Yu, Xiaoqi [1 ]
Yu, Demin [1 ]
Chen, Peizhan [2 ]
Gong, Qiming [3 ]
Zhang, Xinxin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Res Lab Clin Virol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Translat Med Res Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30963-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-218
引用
收藏
页码：E490 / E490
页数：1
相关论文
共 50 条
  • [1] Low serum HBsAg and HBV DNA predict response of peg-interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, S.
    Hansen, B.
    Xie, Q.
    Liang, C.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. -P.
    Fehmi, T.
    Campenhout, M. V.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S518 - S519
  • [2] Quasispecies analysis of HBV strains isolated from chronic hepatitis B patients treated with Peg-interferon plus Tenofovir therapy
    Lada, Olivier
    Zhang, Qian
    Lapalus, Martine
    Cluzeaud, Francoise
    Martinot-Peignoux, Michelle
    Laouenan, Cedric
    Estrabaud, Emilie
    Boyer, Nathalie
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2012, 56 : 429A - 430A
  • [3] QUASISPECIES ANALYSIS OF HBV STRAINS ISOLATED FROM CHRONIC HEPATITIS B PATIENTS TREATED WITH PEG-INTERFERON plus TENOFOVIR THERAPY
    Lada, O.
    Zhang, Q.
    Lapalus, M.
    Laeounan, C.
    Martinot-Peignoux, M.
    Estrabaud, E.
    Boyer, N.
    Asselah, T.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S306 - S306
  • [4] The Significance of Serum HBV Pregenomic RNA in Patients with Low HBsAg Chronic Hepatitis B Following Peg-Interferon Alfa Therapy
    Wang, Menglan
    Chen, Youming
    Lin, Bingliang
    Xie, Dongying
    Deng, Hong
    Lin, Chaoshuang
    Xie, Qifeng
    Zhang, Xiaohong
    Gao, Zhiliang
    HEPATOLOGY, 2018, 68 : 333A - 333A
  • [5] Quasispecies analysis of HBV strains isolated from chronic hepatitis B patients treated with Peg-interferon plus Tenofovir therapy
    Lada, Olivier
    Zhang, Qian
    Laouenan, Cedric
    Martinot-Peignoux, Michelle
    Lapalus, Martine
    Estrabaud, Emilie
    Boyer, Nathalie
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2013, 58 : 722A - 723A
  • [6] HBV RNA in Serum Is an Early Predictor for HBsAg Loss Following Peg-Interferon Treatment for Patients with Hbeag Positive Chronic Hepatitis B
    Farag, Mina
    Van Campenhout, Margo
    van Bommel, Florian
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    Van Vuuren, Anneke J.
    Berg, Thomas
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2018, 68 : 1192A - 1192A
  • [7] Peg-interferon alpha induces CD56bright natural killer cell mediated reduction of HBsAg in entecavir treated chronic Hepatitis B patients
    Shi, Aichao
    Zhang, Xiaoping
    Xiao, Fang
    Yan, Weiming
    Han, Meifang
    Chen, Tao
    Ning, Qin
    HEPATOLOGY, 2017, 66 : 487A - 487A
  • [8] T CELL IMMUNE RESPONSES IN CHRONIC HEPATITIS B PATIENT TREATED WITH PEG-INTERFERON AND ADEFOVIR
    de Niet, Annikki
    Plat-Sinnige, Marjan J. Tempelmans
    Takkenberg, Bart
    Reesink, Hendrik W.
    van Lier, Rene A.
    van Leeuwen, Ester M.
    HEPATOLOGY, 2011, 54 : 1094A - 1095A
  • [9] Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B
    Kosaka, Masanari
    Fujino, Hatsue
    Tsuge, Masataka
    Yamaoka, Kenji
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ono, Atsushi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Hayes, Clair Nelson
    Kashiyama, Seiya
    Mokuda, Sho
    Yamazaki, Shinichi
    Oka, Shiro
    JOURNAL OF GASTROENTEROLOGY, 2025, : 469 - 478
  • [10] HBV RNA IN SERUM IS A PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING TREATMENT WITH PEG-INTERFERON ALPHA-2a (40KD)
    van Boemmel, F.
    van Boemmel, A.
    He, H.
    Wat, C.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S442 - S443
12345